Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


12 Nov 2016 - 16 Nov 2016
16 Nov 2016 - 19 Nov 2016


Desalinated Water Linked to Cases of Iodine Deficiency

A study suggests and warns that relying on desalinated seawater as a population’s main source of drinking water can dramatically increase the prevalence of inadequate iodine intake, recommending individuals use iodized salt or other supplement and monitoring until an effective population-level solution has been found. More...
26 Sep 2016

Human Liver Organoids Thrive When Transplanted into Mouse Liver Failure Model

Liver disease researchers have demonstrated in a mouse model that it may be feasible to treat some types of liver failure with transplanted multicellular liver organoid units composed of a heterogeneous cellular population that includes adult stem and progenitor cells. More...
13 Sep 2016

Novel Human Monoclonal Antibody Shows Promise for Treating Alzheimer's Disease

A human monoclonal antibody that targets aggregated forms of amyloid-beta (Abeta) protein was shown in a phase Ib clinical study to reduce amyloid plaques in patients with early Alzheimer's disease and to slow or prevent cognitive decline in these individuals. More...
12 Sep 2016

Novel Culture Method May Pave the Way for Regeneration of Damaged Kidneys

A three-dimensional (3D) culture method allows long term maintenance of nephron progenitor cells, a type of kidney precursor cell that normally exist only during a brief stage of embryonic development. More...
07 Sep 2016

Gene Editing Corrects Hemoglobin Defects in Beta-Thalassemia and Sickle Cell Disease

A team of hematology researchers used the CRISPR/Cas9 gene editing technique to correct the mutations that cause defective blood cell morphology in beta-thalassemia and sickle cell disease. More...
25 Aug 2016

Laser-Heated Plasmonic Nanoparticles Safely Cause Localized Tumor Destruction

Cancer therapy based on plasmonic nanoparticles that homed to tumors, warmed on exposure to laser irradiation, and then selectively killed the cancer cells was optimized and shown to be effective in a mouse xenograft model. More...
16 Aug 2016

Monoclonal Antibody Treatment Blocks Lymphoma Progression in Mouse Model

Immunotherapy based on monoclonal antibodies that specifically bind to the surface protein junctional adhesion molecule (JAM)-C, which is expressed by a variety of different cell types, including human B lymphocytes and some B-cell lymphoma subtypes, blocked progression of lymphoma in a mouse xenograft model of mantle cell lymphoma. More...
16 Aug 2016

BioResearch Therapeutics channel deals with all aspects of therapies beyond the five-year horizon.
Copyright © 2000-2016 Globetech Media. All rights reserved.